Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-24

Clinical Trial Update: RCT for Pregabalin in Restless Legs Syndrome in South Korea [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of pregabalin for restless legs syndrome has been completed in South Korea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED